Why It’s So Hard to Train Someone to Make an Ethical Decision
Harvard Business Review
JANUARY 11, 2017
Take the decision of Sam Waksal, the former CEO of the emerging biotechnology company ImClone Systems. In late 2001 ImClone awaited approval from the Food and Drug Administration (FDA) of its much-heralded new cancer treatment, but unexpectedly the FDA decided to reject the company’s application.
8 
Let's personalize your content